NCT01457911 - Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin | Biotech Hunter

Enrollment

244

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Glimepiride and Metformin hydrochloride combination (HOE490)

Pharmaceutical form:tablet Route of administration: oral

DRUG

Glimepiride (HOE490)

Pharmaceutical form:tablet Route of administration: oral

Trial Locations (22)

100044

Investigational Site Number 156001, Beijing

100088

Investigational Site Number 156016, Beijing

100730

Investigational Site Number 156003, Beijing

Investigational Site Number 156018, Beijing

100853

Investigational Site Number 156002, Beijing

110022

Investigational Site Number 156021, Shenyang

130041

Investigational Site Number 156019, Changchun

200040

Investigational Site Number 156010, Shanghai

200072

Investigational Site Number 156006, Shanghai

200080

Investigational Site Number 156009, Shanghai

230001

Investigational Site Number 156012, Hefei

250012

Investigational Site Number 156020, Jinan

250021

Investigational Site Number 156023, Jinan

300052

Investigational Site Number 156024, Tianjin

310003

Investigational Site Number 156011, Hangzhou

361003

Investigational Site Number 156015, Xiamen

430022

Investigational Site Number 156008, Wuhan

510080

Investigational Site Number 156014, Guangzhou

510150

Investigational Site Number 156022, Guangzhou

610083

Investigational Site Number 156017, Chengdu

050051

Investigational Site Number 156005, Shijiazhuang

030001

Investigational Site Number 156004, Taiyuan